Coverage of a national cardiovascular risk assessment and management programme (NHS Health Check): Retrospective database study

Preventive Medicine

Volumn 78, Issue , 2015, Pages 1-8

  Chang, Kiara Chu Mei ^a   Soljak, Michael ^a   Lee, John Tayu ^a   Woringer, Maria ^a   Johnston, Desmond ^a   Khunti, Kamlesh ^b   Majeed, Azeem ^a   Millett, Christopher ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cardiovascular disease; Primary prevention; Risk assessment; Screening

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLACK PERSON; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FACTUAL DATABASE; FAMILY HISTORY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH SERVICE; POVERTY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROGRAM EVALUATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK MANAGEMENT; SOCIAL STATUS; UNITED KINGDOM; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; ENGLAND; EPIDEMIOLOGY; ETHNOLOGY; EVALUATION STUDY; INFORMATION PROCESSING; PROTOCOL COMPLIANCE; REGRESSION ANALYSIS; STANDARDS;

ADULT; AGED; CARDIOVASCULAR DISEASES; DATASETS AS TOPIC; DISEASE MANAGEMENT; ENGLAND; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PREVALENCE; PROGRAM EVALUATION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATE MEDICINE;

EID: 84936754011     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2015.05.022     Document Type: Article

References (31)

1. Anderson K.M., Odell P.M., Wilson P.W., Kannel W.B. Cardiovascular disease risk profiles. Am. Heart J. 1991, 121(1):293-298.
2. Artac M., Dalton A.R., Babu H., Bates S., Millett C., Majeed A. Primary care and population factors associated with NHS Health Check coverage: a national cross-sectional study. J. Public Health 2013, 35(3):431-439.
3. Artac M., Dalton A.R., Majeed A., Car J., Huckvale K., Millett C. Uptake of the NHS Health Check programme in an urban setting. Fam. Pract. 2013, 30(4):426-435.
4. Booth N. What are the read codes?. Health Libr. Rev. 1994, 11(3):177-182.
5. Cochrane T., Gidlow C.J., Kumar J., Mawby Y., Iqbal Z., Chambers R.M. Cross-sectional review of the response and treatment uptake from the NHS Health Checks programme in Stoke on Trent. J. Public Health (Oxf.) 2013, 35(1):92-98.
6. Cooper A., Nherera L., Calvert N., et al. Clinical guidelines and evidence review for lipid modification: cardiovascular risk assessment and the primary and secondary prevention of cardiovascular disease. Lipid Modification: Full Guideline May 2008, National Collaborating Centre for Primary Care and Royal College of General Practitioners, London.
7. Dalton A.R., Bottle A., Okoro C., Majeed A., Millett C. Uptake of the NHS Health Checks programme in a deprived, culturally diverse setting: cross-sectional study. J. Public Health 2011, 33(3):422-429.
8. Department of Health Putting Prevention First-NHS Health Check: Vascular Risk Assessment and Management Best Practice Guidance 2009.
9. Duff P.S.G. Independent Scientific Advisory Committee for Medicines and Healthcare Products Regulatory Agency (MHRA) Database Research Annual Report 2012.
10. Ebrahim S., Casas J.P. Statins for all by the age of 50years?. Lancet 2012, 380(9841):545-547.
11. Frieden T.R., Berwick D.M. The "million hearts" initiative - preventing heart attacks and strokes. N. Engl. J. Med. 2011, 365(13):e27.
12. Health and Social Care Information Centre. Health Survey for England - 2012, Trend tables: Adult trend tables.
13. Herrett E., Thomas S.L., Schoonen W.M., Smeeth L., Hall A.J. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br. J. Clin. Pharmacol. 2010, 69(1):4-14.
14. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., Brindle P. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 2008, 94(1):34-39.
15. Lad M. The English Indices of Deprivation 2010 2011, Department for Communities and Local Government.
16. Lawrenson R., Williams T., Farmer R. Clinical information for research; the use of general practice databases. J. Public Health Med. 1999, 21(3):299-304.
17. Lewis J.D., Brensinger C. Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol. Drug Saf. 2004, 13(7):437-441.
18. Merlo J., Chaix B., Ohlsson H., et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J. Epidemiol. Community Health 2006, 60(4):290-297.
19. Ministry of Health Health targets: more heart and diabetes checks Available from:, (Accessed 24th March 2015). http://www.health.govt.nz/new-zealand-health-system/health-targets/about-health-targets/health-targets-more-heart-and-diabetes-checks.
20. Mohammed M.A., El Sayed C., Marshall T. Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment. Med. Decis. Mak. 2012, 32(3):498-506.
21. Murray C.J., Vos T., Lozano R., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380(9859):2197-2223.
22. National Institute for Health and Care Excellence Lipid modification-cardiovascular risk assessment and modification of blood lipids for the primary and secondary prevention of cardiovascular disease: National Institute for Health and Care Excellence 2014.
23. NHS Information Centre for Health and Social Care NHS Health Check Exclusion Read Codes http://www.hscic.gov.uk/nhshealthcheck.
24. NHS Information Centre for Health and Social Care NHS Health Check Data Set Read Code Mapping Guidance. Leeds: The NHS Information Centre 2011.
25. Robinson J.G. Accumulating evidence for statins in primary prevention. JAMA 2013, 310(22):2405-2406.
26. Townsend N., Wickramasinghe K., Bhatnagar P., et al. Coronary Heart Disease Statistics 2012 Edition 2012, British Heart Foundation, London.
27. van Staa T.-P., Smeeth L., Ng E.S., Goldacre B., Gulliford M. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?. Heart 2013, 99(21):1597-1602.
28. Wood D., Wray R., Poulter N., et al. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005, 91.
29. World Health Organisation Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings 2010.
30. World Health Organization Global action plan for the prevention and control of noncommunicable diseases 2013-2020 2013.
31. Wu J., Zhu S., Yao G.L., Mohammed M.A., Marshall T. Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study. PLoS One 2013, 8(7):e67611.